Gemcitabin in der First-line-Therapie des lokal fortgeschrittenen und metastasierten nicht-kleinzelligen Bronchialkarzinoms (NSCLC): Ergebnisübersicht randomisierter Phase-III-Studien

Publisher： Karger

E-ISSN： 2296-5262|28|1|1-28

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.28, Iss.1, 2005-03, pp. : 1-28

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Docetaxel (Taxotere®) in der First-line-Therapie des fortgeschrittenen nicht-kleinzelligen Bronchialkarzinoms (NSCLC)

By  

Oncology Research and Treatment, Vol. 26, Iss. 7, 2004-11 ,pp. : 26-32

Karger

Access to resources Recommend Favorite

Therapie des nicht kleinzelligen Lungenkarzinoms (NSCLC) im lokal fortgeschrittenen Stadium (inoperables IIIA/IIIB)

By  

Oncology Research and Treatment, Vol. 29, Iss. 2, 2006-09 ,pp. : 11-14

Karger

Access to resources Recommend Favorite

Kombination mit Irinotecan – die Referenztherapie in der First-line-Therapie des fortgeschrittenen Kolorektalkarzinoms

By  

Oncology Research and Treatment, Vol. 23, Iss. 6, 2004-11 ,pp. : 32-34

Karger

Access to resources Recommend Favorite

Operation und adjuvante Therapie des nicht kleinzelligen Lungenkarzinoms (NSCLC) (Stadium I bis operables IIIA)

By  

Oncology Research and Treatment, Vol. 29, Iss. 2, 2006-09 ,pp. : 7-10

Karger

Access to resources Recommend Favorite

Therapie des nicht kleinzelligen Lungenkarzinoms (NSCLC) im Stadium IV

By  

Oncology Research and Treatment, Vol. 29, Iss. 2, 2006-09 ,pp. : 15-19

Karger

Access to resources Recommend Favorite